The Federal Court ordered that Peptide Clinics Australia pay $10 million to the Commonwealth for breaches of the mandatory rules for advertising of medicines, including the ban on advertising prescription-only medicines to the public.
GSK and Novartis admitted that from January 2012 to March 2017, they marketed Osteo Gel as being specifically formulated and more effective than Emulgel in treating osteoarthritis related pain and inflammation. In fact, Osteo Gel and Emulgel products are essentially the same.
Following investigations by the Therapeutic Goods Administration (TGA) the Adelaide Magistrates Court sentenced a South Australian man in relation to illegal acts involving counterfeit therapeutic goods.
Peptide Clinics Australia is alleged to have advertised compounded prescription only therapeutic goods, including ‘peptides’, on its website and other social media platforms, accessible to both registered customers and the public.
The Federal Court has ordered hearing aid retailers Oticon Australia and Sonic Innovations to pay penalties totalling $2.5 million for misleading pensioners through newspaper advertisements for hearing aids sold by AudioClinic and HearingLife clinics.
A New South Wales Chinese medicine practitioner has been convicted of unlawful advertising of a regulated health service after an investigation by the Australian Health Practitioner Regulation Agency (AHPRA).